Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma [Phase 1, Phase 2]

View source ↗

Summary

An early-phase vaccine therapy trial for stage IV cutaneous melanoma has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University Hospital Erlangen | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED